Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

active pharmaceutical...

Tag: active pharmaceutical ingredients

Read all Latest Updates and news about Active pharmaceutical Ingridients - Page 2

An active pharmaceutical ingredient is the ingredient in a pharma drug or pesticide that is biologically active also known as bulk drugs - Find out all latest information on APIs.

API exports stood at Rs 32,856 crore, imports at Rs 28,529 crore in FY21: Mansukh Mandaviya

Ruchika Sharma5 Aug 2021 10:00 AM IST

New Delhi: For the financial year 2020-21, imports of active pharmaceutical ingredients stood at Rs 28,529 crore while exports were at Rs 32,856...

Already approved drugs with changes in active substance may be considered as new drug: DCGI

Medical Dialogues Team26 July 2021 10:00 AM IST

New Delhi: The apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has clarified that any changes in...

Pharma PLI scheme will reduce dependence on API imports: India Ratings and Research

Ruchika Sharma6 July 2021 10:00 AM IST

New Delhi: India's production-linked incentive (PLI) scheme will reduce India's dependence on imports for key active pharmaceutical ingredients (APIs)...

DoP issues operational guidelines for PLI Scheme for pharma industry

Medical Dialogues Team5 Jun 2021 10:00 AM IST

New Delhi: With an aim to enhance India's manufacturing capabilities by increasing investment and production in the pharmaceutical sector and to...

DCGI seeks information on API stock to check hoarding, price hike

Medical Dialogues Team21 May 2021 6:11 PM IST

Solan: To eliminate unlawful activities and monitor the sudden increase in the price of Active Pharmaceutical Ingredients (APIs), the Drugs Controller...

Hikal signs 10-year deal with global pharma firm for APIs

Ruchika Sharma8 May 2021 1:34 PM IST

New Delhi: Life sciences firm Hikal Ltd on Wednesday said it has signed a 10-year deal with a global pharmaceutical company for development and supply...

Govt Bans 35 Combination Drugs, See Full List

Banned: No more exports of Remdesivir out of India

Medical Dialogues Bureau12 April 2021 11:35 AM IST

Seven Indian companies are producing Injection Remdesivir under a voluntary licensing agreement with Gilead Sciences, USA

Govt nod to 33 API applications with over Rs 5k crore committed investment under PLI scheme

Ruchika Sharma14 March 2021 10:30 AM IST

New Delhi: The government has approved a total of 33 applications with a committed investment of Rs 5,082.65 crore under the production linked...

Dr Reddy's labs gets USFDA 3 observations for New York API facility

Ruchika Sharma11 March 2021 12:21 PM IST

New Delhi: Dr Reddy's Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its...

IT raids at Hyderabad-based pharma group, Rs 400 crore Black income detected: CBDT

Ruchika Sharma2 March 2021 1:16 PM IST

New Delhi: The Income Tax Department has detected "unaccounted" income of about Rs 400 crore after raids on a major pharmaceutical group based in...

Realisation there in pharma industry to become self reliant in API production: IPA

Ruchika Sharma26 Feb 2021 9:00 AM IST

Jain however noted that it will take some time for the country to get self reliance in API production.

Seeking to end reliance on China, Indian pharma firms go local for APIs

Ruchika Sharma24 Feb 2021 11:50 AM IST

Executives at India's Cadila Healthcare, Cipla, Sun Pharmaceutical, and Biocon said on Tuesday they were aggressively working on reducing the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok